 |
Histamine |
|---|---|
| Trade Name | Maxamine |
| Orphan Indication | For use as an adjunct to cytokine therapy in the treatment of malignant melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2000-02-01 00:00:00 |
| Sponsor | EpiCept Corporation;777 Old Saw Mill River Road;Tarrytown, New York, 10591 |
